Tibet Cheezheng Tibetan Medicine Co., Ltd.
Sümbol: 002287.SZ
SHZ
22.21
CNYTuruhind täna
20.1008
P/E suhe
0.0000
PEG suhe
11.78B
MRK Cap
- 0.02%
DIV tootlus
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287-SZ) Finantsaruanded
Bilanss
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 10005.55 | 2366.5 | 1976.9 | 1850.6 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 8430.88 | 1963 | 1539.3 | 1184 | ||||||||||||||||||
balance-sheet.row.net-receivables | 3258.11 | 663.5 | 841.2 | 629.6 | ||||||||||||||||||
balance-sheet.row.inventory | 642.83 | 156.3 | 127.8 | 118.5 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 87.71 | 8 | 246.6 | 337.7 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 14048.36 | 3194.4 | 3192.4 | 2936.4 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 5861.27 | 1651.6 | 1144.4 | 821.4 | ||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 1413.28 | 351.6 | 374.8 | 399.3 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1413.28 | 351.6 | 374.8 | 399.3 | ||||||||||||||||||
balance-sheet.row.long-term-investments | -561.9 | 1056.5 | -423.1 | -42.4 | ||||||||||||||||||
balance-sheet.row.tax-assets | 139.57 | 39.4 | 29.1 | 26.7 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | 5055.39 | 4.9 | 1568.9 | 1426.4 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 11907.61 | 3104.1 | 2694.2 | 2631.4 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 25955.97 | 6298.5 | 5886.6 | 5567.8 | ||||||||||||||||||
balance-sheet.row.account-payables | 744.05 | 255.6 | 93.5 | 184 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 3466.68 | 478 | 762.3 | 610.8 | ||||||||||||||||||
balance-sheet.row.tax-payables | 237.12 | 55.6 | 61.9 | 37.7 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 4253.1 | 1061.3 | 934.4 | 841.4 | ||||||||||||||||||
Deferred Revenue Non Current | 754.86 | 191.3 | 167 | 154.7 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 127.94 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 460.38 | 437.7 | 402.2 | 4.6 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 4959.4 | 1089.2 | 1138.9 | 1039.4 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 21.98 | 7 | 4.9 | 4.9 | ||||||||||||||||||
balance-sheet.row.total-liab | 11067.61 | 2334.4 | 2499 | 2347.4 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 471.98 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.common-stock | 2120.75 | 530.2 | 530.2 | 530.3 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 8154.57 | 2104.1 | 1784.8 | 1667 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 2375.97 | 631.3 | 566.4 | 507.4 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1369.17 | 454.7 | 454.6 | 464.3 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 14492.44 | 3720.3 | 3336 | 3169 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 25955.97 | 6298.5 | 5886.6 | 5567.8 | ||||||||||||||||||
balance-sheet.row.minority-interest | 202.02 | 49.8 | 51.6 | 51.4 | ||||||||||||||||||
balance-sheet.row.total-equity | 14694.46 | 3770.1 | 3387.7 | 3220.4 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 25955.97 | - | - | - | ||||||||||||||||||
Total Investments | 5660.63 | 3019.6 | 1116.2 | 1141.6 | ||||||||||||||||||
balance-sheet.row.total-debt | 7726.78 | 1546.3 | 1696.7 | 1452.2 | ||||||||||||||||||
balance-sheet.row.net-debt | 6152.1 | 1142.9 | 1259.1 | 785.6 |
Rahavoogude aruanne
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 585.9 | 581.2 | 469.5 | 710.8 | ||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 7.51 | 95.8 | 83.2 | 65.8 | ||||||||||||||||||
cash-flows.row.deferred-income-tax | -17.2 | -24.3 | -8.3 | 38.8 | ||||||||||||||||||
cash-flows.row.stock-based-compensation | 0.87 | -168.3 | 3.6 | 4.9 | ||||||||||||||||||
cash-flows.row.change-in-working-capital | 38 | 47.8 | -374.7 | 521.1 | ||||||||||||||||||
cash-flows.row.account-receivables | 41.95 | 42 | -209.3 | 369.7 | ||||||||||||||||||
cash-flows.row.inventory | -28.46 | -28.5 | -10.6 | -24 | ||||||||||||||||||
cash-flows.row.account-payables | 0 | 9.8 | -146.4 | 136.6 | ||||||||||||||||||
cash-flows.row.other-working-capital | 24.51 | 24.5 | -8.3 | 38.8 | ||||||||||||||||||
cash-flows.row.other-non-cash-items | 320.18 | 439.6 | 112.5 | -306.5 | ||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 934.39 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -254.94 | -234.8 | -272.4 | -125.6 | ||||||||||||||||||
cash-flows.row.acquisitions-net | -0.56 | -0.6 | -3.8 | -61.1 | ||||||||||||||||||
cash-flows.row.purchases-of-investments | -1450 | -1492.4 | -1418 | -3494.7 | ||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 1063.16 | 1138.1 | 1355.9 | 1526 | ||||||||||||||||||
cash-flows.row.other-investing-activites | -229.98 | 0 | 3.8 | 0 | ||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -642.34 | -589.7 | -334.5 | -2155.4 | ||||||||||||||||||
cash-flows.row.debt-repayment | -1492.91 | -201.8 | -637.8 | -341.8 | ||||||||||||||||||
cash-flows.row.common-stock-issued | -250.46 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.5 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.dividends-paid | -219.61 | -206.7 | -340.5 | -195.5 | ||||||||||||||||||
cash-flows.row.other-financing-activites | 1205.14 | -13.3 | 795.1 | 494.6 | ||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -92.13 | -431.9 | -183.2 | -42.8 | ||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 1.14 | 0.6 | 3 | -0.7 | ||||||||||||||||||
cash-flows.row.net-change-in-cash | 215.99 | -34.1 | -229.1 | -1164 | ||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1573.63 | 403.4 | 437.6 | 666.6 | ||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1357.64 | 437.6 | 666.6 | 1830.6 | ||||||||||||||||||
cash-flows.row.operating-cash-flow | 934.39 | 971.9 | 285.7 | 1034.9 | ||||||||||||||||||
cash-flows.row.capital-expenditure | -254.94 | -234.8 | -272.4 | -125.6 | ||||||||||||||||||
cash-flows.row.free-cash-flow | 679.46 | 737.1 | 13.3 | 909.3 |
Kasumiaruande rida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 2101.04 | 2010.3 | 2044.8 | 1770.5 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 349.53 | 382.4 | 324.1 | 265.3 | ||||||||||||||||||
income-statement-row.row.gross-profit | 1751.51 | 1627.9 | 1720.6 | 1505.1 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 58 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 52.87 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1004.63 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | -3.15 | 0.8 | 78 | 50.5 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 1191.78 | 1161.6 | 1118.9 | 1007.3 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 1541.31 | 1544 | 1443.1 | 1272.6 | ||||||||||||||||||
income-statement-row.row.interest-income | 10.54 | 13.1 | 17 | 34.4 | ||||||||||||||||||
income-statement-row.row.interest-expense | 63.33 | 63.1 | 56.4 | 53.4 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1004.63 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 130.43 | 176.2 | -2.3 | -2.3 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | -3.15 | 0.8 | 78 | 50.5 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | 130.43 | 176.2 | -2.3 | -2.3 | ||||||||||||||||||
income-statement-row.row.interest-expense | 63.33 | 63.1 | 56.4 | 53.4 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 61.27 | 95.8 | 143.9 | 111 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 598.17 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 569.73 | 466.3 | 521.5 | 790.2 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 672.15 | 642.5 | 519.2 | 787.9 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 73.04 | 65.2 | 49.7 | 77.1 | ||||||||||||||||||
income-statement-row.row.net-income | 585.9 | 581.2 | 472.5 | 715.9 |
Korduma kippuv küsimus
Mis on Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) koguvara?
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) koguvara on 6298478593.000.
Mis on ettevõtte aastane tulu?
Aastane tulu on 1150739074.000.
Mis on ettevõtte kasumimarginaal?
Ettevõtte kasumimarginaal on 0.834.
Mis on ettevõtte vaba rahavoog?
Vaba rahavoog on 1.281.
Mis on ettevõtte puhaskasumimarginaal?
Puhaskasumimarginaal on 0.279.
Mis on ettevõtte kogutulu?
Kogutulu on 0.271.
Mis on Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) puhaskasum (puhaskasum)?
Puhaskasum (netotulu) on 581198850.000.
Kui suur on ettevõtte koguvõlg?
Koguvõlg on 1546314759.000.
Mis on tegevuskulude arv?
Tegevuskulud on 1161615874.000.
Milline on ettevõtte rahaline näitaja?
Ettevõtte raha on 357241866.000.